Analysts recommend Hindustan Copper and Concord Biotech after both stocks broke key resistance levels with strong price action, volume and bullish momentum. Despite energy-led cost pressures, stronger Q1FY27 earnings and pricing actions could support upgrades, though margin risks remain from higher-cost inventory.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.